by Vora Corporate Finance | Feb 24, 2024 | Insights
Secondary Market: The BSE Sensex closed at71,752.11 by -0.68% and the Nifty 50 closed at 21,725.70 by -0.03% in the month of January 2024. There’s a noticeable rally in cyclical stocks, driven by the broader economic outlook and expectations of growth. The increased...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Economic Update: Finance and Corporate Affairs Minister Smt. Nirmala Sitharaman presented the Interim Union Budget for 2024-25 in the parliament. Finance minister highlighted that Indian economy has demonstrated resilience and maintained healthy macro-economic...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Private Equity & IPO
PE: PlasmaGen Biosciences Raises $27 Million in Series C round. Transaction: Plasmagen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, has raised INR 225 crores, led by UK based Artian...
by Vora Corporate Finance | Jan 27, 2024 | Articles, Capital Market Updates
The Indian economy grew 7.6 per cent during the July – September quarter of the current financial year(Q2FY24), beating the earlier projections by RBI. The rise in GDP was supported by manufacturing, mining and construction sector. The stock markets also...
by Vora Corporate Finance | Jan 5, 2024 | Insights, Private Equity & IPO
Transaction: InCred Financial Services Ltd (InCred Finance), the lending arm of financial services firm InCred Group, has raised Rs. 500 Crore in its Series D round of funding, becoming the second startup to join the coveted ‘unicorn’ club this year. About Incred...
